Encellin Company
Encellin develops a novel thin-film cell encapsulation device for cell-based therapeutics. It has dedicated experts focused on the investigation and advancement of next-generation therapies. It aims to help patients with chronic diseases, starting with Type 1 diabetes. It was founded in 2016 and is headquartered in San Francisco, California.
Industry:
PharmTech
Headquarters:
San Francisco, California, United States
Zip:
1-10
Founded Date:
2016-01-01
Employees Number:
1-10
Acquisitions Number:
6
Investors Number:
5900000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
info@encellin.com
Register and Claim Ownership